Long COVID sufferers get new hope from 6-Week day program

NCT ID NCT05532904

First seen Nov 01, 2025 · Last updated Jun 19, 2026 · Updated 37 times

Summary

This study tested a 6-week personalized day-hospital program for people with persistent long COVID symptoms like fatigue, shortness of breath, and brain fog. The program included group education, exercise training, and cognitive behavioral therapy. Researchers compared the quality of life of 80 participants who received the program to those on a waiting list. The goal was to see if this multidisciplinary approach could improve well-being.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POST-COVID-19 CONDITION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Hôtel Dieu Hospital

    Paris, 75004, France

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

personalized multidisciplinary day-hospital program (education, exercise, cognitive behavioral therapy)

What this could lead to

If it works, this could point toward an effective structured program to improve quality of life for people with long COVID.

What could go wrong

This is a small, completed trial with only 80 participants, so results may not apply to everyone. The program is intensive and may not be widely available.

Conditions

The condition(s) this trial relates to.

Motor Activity post-COVID-19 disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.